{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:44:48Z","timestamp":1781531088292,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10822-018-0117-y","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T04:34:30Z","timestamp":1524458070000},"page":"633-642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["DR2DI: a powerful computational tool for predicting novel drug-disease associations"],"prefix":"10.1007","volume":"32","author":[{"given":"Lu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-1139","authenticated-orcid":false,"given":"Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"117_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","volume":"9","author":"SM Paul","year":"2010","unstructured":"Paul SM et al (2010) How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge. Nat Rev Drug Discov 9:203\u2013214","journal-title":"Nat Rev Drug Discov"},{"key":"117_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/wsbm.1337","volume":"8","author":"RA Hodos","year":"2016","unstructured":"Hodos RA et al (2016) In silico methods for drug repurposing and pharmacology. Wiley Interdiscip Rev Syst Biol Med 8:186","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"117_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fphar.2017.00298","volume":"8","author":"E March-Vila","year":"2017","unstructured":"March-Vila E et al (2017) On the integration of in silico drug design methods for drug repurposing. Front Pharmacol 8:298","journal-title":"Front Pharmacol"},{"key":"117_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.drudis.2016.09.019","volume":"22","author":"Q Vanhaelen","year":"2016","unstructured":"Vanhaelen Q et al (2016) Design of efficient computational workflows for in silico drug repurposing. Drug Discovery Today 22:210\u2013222","journal-title":"Drug Discovery Today"},{"key":"117_CR5","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/nbt.2758","volume":"31","author":"ZY Wang","year":"2013","unstructured":"Wang ZY, Zhang HY (2013) Rational drug repositioning by medical genetics. Nat Biotechnol 31:1080","journal-title":"Nat Biotechnol"},{"key":"117_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/clpt.2013.1","volume":"93","author":"MR Hurle","year":"2013","unstructured":"Hurle MR et al (2013) Computational drug repositioning: from data to therapeutics. Clin Pharmacol Ther 93:335\u2013341","journal-title":"Clin Pharmacol Ther"},{"key":"117_CR7","doi-asserted-by":"publisher","first-page":"D1060","DOI":"10.1093\/nar\/gkq1037","volume":"39","author":"J Eichborn von","year":"2011","unstructured":"von Eichborn J et al (2011) PROMISCUOUS: a database for network-based drug-repositioning. Nucleic Acids Res 39:D1060\u2013D1066","journal-title":"Nucleic Acids Res"},{"key":"117_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart DS et al (2008) DrugBank: a knowledge base for drugs, drug actions and drug targets. Nucleic Acids Res 36:901\u2013906","journal-title":"Nucleic Acids Res"},{"key":"117_CR9","doi-asserted-by":"publisher","first-page":"D786","DOI":"10.1093\/nar\/gkn580","volume":"37","author":"AP Davis","year":"2009","unstructured":"Davis AP et al (2009) Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks. Nucleic Acids Res 37:D786","journal-title":"Nucleic Acids Res"},{"key":"117_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/nar\/30.1.412","volume":"30","author":"X Chen","year":"2002","unstructured":"Chen X, Ji ZL, Chen YZ (2002) TTD: Therapeutic target Database. Nucleic Acids Res 30:412\u2013415","journal-title":"Nucleic Acids Res"},{"key":"117_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1021\/ci500670q","volume":"55","author":"H Iwata","year":"2015","unstructured":"Iwata H et al (2015) Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data. J Chem Inf Model 55:446\u2013459","journal-title":"J Chem Inf Model"},{"key":"117_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/bib\/bbr013","volume":"12","author":"JT Dudley","year":"2011","unstructured":"Dudley JT, Deshpande T, Butte AJ (2011) Exploiting drug-disease relationships for computational drug repositioning. Briefings Bioinf 12:303\u2013311","journal-title":"Briefings Bioinf"},{"key":"117_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/msb.2011.26","volume":"7","author":"A Gottlieb","year":"2011","unstructured":"Gottlieb A et al (2011) PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol 7:496","journal-title":"Mol Syst Biol"},{"key":"117_CR14","doi-asserted-by":"publisher","first-page":"e28025","DOI":"10.1371\/journal.pone.0028025","volume":"6","author":"L Yang","year":"2011","unstructured":"Yang L, Agarwal P (2011) Systematic drug repositioning based on clinical side-effects. PLoS ONE 6:e28025","journal-title":"PLoS ONE"},{"key":"117_CR15","doi-asserted-by":"publisher","first-page":"e78518","DOI":"10.1371\/journal.pone.0078518","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang Y et al (2013) Drug repositioning by Kernel-based integration of molecular structure, molecular activity, and phenotype data. PLoS ONE 8:e78518","journal-title":"PLoS ONE"},{"key":"117_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1758-2946-5-30","volume":"5","author":"F Napolitano","year":"2013","unstructured":"Napolitano F et al (2013) Drug repositioning: a machine-learning approach through data integration. J Cheminf 5:30","journal-title":"J Cheminf"},{"key":"117_CR17","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/bioinformatics\/btw591","volume":"33","author":"X Liang","year":"2017","unstructured":"Liang X et al (2017) LRSSL: predict and interpret drug-disease associations based on data integration using sparse subspace learning. Bioinformatics 33:1187\u20131196","journal-title":"Bioinformatics"},{"key":"117_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/clpt.2009.103","volume":"86","author":"AP Chiang","year":"2009","unstructured":"Chiang AP, Butte AJ (2009) Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin Pharmacol Ther 86:507\u2013510","journal-title":"Clin Pharmacol Ther"},{"key":"117_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-1","volume":"14","author":"J Li","year":"2013","unstructured":"Li J, Lu Z (2013) Pathway-based drug repositioning using causal inference. BMC Bioinf 14:1\u201310","journal-title":"BMC Bioinf"},{"key":"117_CR20","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1039\/C4MB00014E","volume":"10","author":"N Pratanwanich","year":"2014","unstructured":"Pratanwanich N, Li\u00f3 P (2014) Pathway-based Bayesian inference of drug-disease interactions. Mol Biosyst 10:1538","journal-title":"Mol Biosyst"},{"key":"117_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-014-0052-z","volume":"6","author":"I Vogt","year":"2014","unstructured":"Vogt I, Prinz J, Campillos M (2014) Molecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairs. Genome Med 6:1\u201317","journal-title":"Genome Med"},{"key":"117_CR22","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1021\/ci500340n","volume":"54","author":"J Yang","year":"2014","unstructured":"Yang J et al (2014) Drug-disease association and drug-repositioning predictions in complex diseases using causal inference-probabilistic matrix factorization. J Chem Inf Model 54:2562","journal-title":"J Chem Inf Model"},{"key":"117_CR23","doi-asserted-by":"publisher","first-page":"e87864","DOI":"10.1371\/journal.pone.0087864","volume":"9","author":"H Ye","year":"2014","unstructured":"Ye H, Liu Q, Wei J (2014) Construction of drug network based on side effects and its application for drug repositioning. PLoS ONE 9:e87864","journal-title":"PLoS ONE"},{"key":"117_CR24","doi-asserted-by":"publisher","first-page":"e6536","DOI":"10.1371\/journal.pone.0006536","volume":"4","author":"G Hu","year":"2009","unstructured":"Hu G, Agarwal P (2009) Human disease-drug network based on genomic expression profiles. PLoS One 4:e6536","journal-title":"PLoS One"},{"key":"117_CR25","doi-asserted-by":"publisher","first-page":"14621","DOI":"10.1073\/pnas.1000138107","volume":"107","author":"F Iorio","year":"2010","unstructured":"Iorio F et al (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA 107:14621\u201314626","journal-title":"Proc Natl Acad Sci USA"},{"key":"117_CR26","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J et al (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929\u20131935","journal-title":"Science"},{"key":"117_CR27","doi-asserted-by":"publisher","first-page":"e1002347","DOI":"10.1371\/journal.pcbi.1002347","volume":"8","author":"D Shigemizu","year":"2012","unstructured":"Shigemizu D et al (2012) Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer. PLoS Comput Biol 8:e1002347","journal-title":"PLoS Comput Biol"},{"key":"117_CR28","doi-asserted-by":"publisher","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","volume":"3","author":"M Sirota","year":"2011","unstructured":"Sirota M et al (2011) Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 3:96ra77","journal-title":"Sci Transl Med"},{"key":"117_CR29","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1039\/c3mb25309k","volume":"9","author":"F Cheng","year":"2013","unstructured":"Cheng F et al (2013) Prediction of human genes and diseases targeted by xenobiotics using predictive toxicogenomic-derived models (PTDMs). Mol Biosyst 9:1316\u20131325","journal-title":"Mol Biosyst"},{"key":"117_CR30","doi-asserted-by":"publisher","first-page":"e1002503","DOI":"10.1371\/journal.pcbi.1002503","volume":"8","author":"F Cheng","year":"2012","unstructured":"Cheng F et al (2012) Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol 8:e1002503","journal-title":"PLoS Comput Biol"},{"key":"117_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-8794-6-S3-S4","volume":"6","author":"YF Huang","year":"2013","unstructured":"Huang YF, Yeh HY, Soo VW (2013) Inferring drug-disease associations from integration of chemical, genomic and phenotype data using network propagation. BMC Med Genomics 6:1\u201314","journal-title":"BMC Med Genomics"},{"key":"117_CR32","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/bioinformatics\/btu403","volume":"30","author":"W Wang","year":"2014","unstructured":"Wang W et al (2014) Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics 30:2923","journal-title":"Bioinformatics"},{"key":"117_CR33","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1039\/c3mb25382a","volume":"9","author":"Z Wu","year":"2013","unstructured":"Wu Z, Wang Y, Chen L (2013) Network-based drug repositioning. Mol Biosyst 9:1268\u20131281","journal-title":"Mol Biosyst"},{"key":"117_CR34","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1289\/ehp.6028","volume":"111","author":"GT Colby","year":"2003","unstructured":"Colby GT (2003) The comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies. Environ Health Perspect 111:793","journal-title":"Environ Health Perspect"},{"key":"117_CR35","doi-asserted-by":"publisher","first-page":"D972","DOI":"10.1093\/nar\/gkw838","volume":"45","author":"AP Davis","year":"2017","unstructured":"Davis AP et al (2017) The comparative Toxicogenomics Database: update 2017. Nucleic Acids Res 45:D972\u2013D978","journal-title":"Nucleic Acids Res"},{"key":"117_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.yebeh.2003.12.001","volume":"5","author":"C Harden","year":"2004","unstructured":"Harden C, Maclusky NJ (2004) Aromatase inhibition, testosterone, and seizures. Epilepsy Behav 5:260\u2013263","journal-title":"Epilepsy Behav"},{"key":"117_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuroscience.2004.08.002","volume":"129","author":"DS Reddy","year":"2004","unstructured":"Reddy DS (2004) Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol. Neuroscience 129:195","journal-title":"Neuroscience"},{"key":"117_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.genhosppsych.2007.01.009","volume":"29","author":"R Goyal","year":"2007","unstructured":"Goyal R, Chandrasekaran R, Nanda MR (2007) Propranolol-responsive akathisia following acute encephalitis. Gen Hosp Psychiatry 29:273\u2013274","journal-title":"Gen Hosp Psychiatry"},{"key":"117_CR39","doi-asserted-by":"publisher","first-page":"16_suppl","DOI":"10.1200\/jco.2005.23.16_suppl.3200","volume":"23","author":"A Restivo","year":"2005","unstructured":"Restivo A et al (2005) Antiproliferative effect of mimosine in ovarian cancer. J Clin Oncol 23:16_suppl","journal-title":"J Clin Oncol"},{"key":"117_CR40","unstructured":"Kawakita T et al (1999) Benzoic acid compounds and use thereof as medicaments. US Patent No. 5,864,039"},{"key":"117_CR41","first-page":"82","volume":"60","author":"P Sharma","year":"2016","unstructured":"Sharma P, Pandey R, Deshpande S (2016) Indomethacin exacerbates oleic acid-induced acute respiratory distress syndrome in adult rats. Indian J Physiol Pharmacol 60:82\u201389","journal-title":"Indian J Physiol Pharmacol"},{"key":"117_CR42","unstructured":"Zhang P et al (2013) Exploring the relationship between drug side-effects and therapeutic indications. In: AMIA annual symposium proceedings, vol.\u00a02013, pp\u00a01568\u20131577"},{"key":"117_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bioinformatics\/btq600","volume":"27","author":"TV Laarhoven","year":"2011","unstructured":"Laarhoven TV, Nabuurs SB, Marchiori E (2011) Gaussian interaction profile kernels for predicting drug\u2013target interaction. Bioinformatics 27:1\u20138","journal-title":"Bioinformatics"},{"key":"117_CR44","doi-asserted-by":"publisher","first-page":"43792","DOI":"10.1038\/srep43792","volume":"7","author":"H Yu","year":"2017","unstructured":"Yu H, Chen X, Lu L (2017) Large-scale prediction of microRNA-disease associations by combinatorial prioritization algorithm. Sci Rep 7:43792","journal-title":"Sci Rep"},{"key":"117_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-642-15939-8_9","volume-title":"European conference on machine learning and knowledge discovery in databases","author":"R Raymond","year":"2010","unstructured":"Raymond R, Kashima H (2010) Fast and scalable algorithms for semi-supervised link prediction on static and dynamic graphs. In: European conference on machine learning and knowledge discovery in databases, vol\u00a01. Springer, Heidelberg, pp\u00a0131\u2013147"},{"key":"117_CR46","doi-asserted-by":"publisher","first-page":"e37608","DOI":"10.1371\/journal.pone.0037608","volume":"7","author":"H Yu","year":"2012","unstructured":"Yu H et al (2012) A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data. Plos ONE 7:e37608","journal-title":"Plos ONE"},{"key":"117_CR47","doi-asserted-by":"publisher","first-page":"e1005111","DOI":"10.1371\/journal.pcbi.1005111","volume":"12","author":"P Jeanette","year":"2016","unstructured":"Jeanette P et al (2016) A novel drug-mouse phenotypic similarity method detects molecular determinants of drug effects. PLoS Comput Biol 12:e1005111","journal-title":"PLoS Comput Biol"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-018-0117-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-018-0117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-018-0117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T19:53:36Z","timestamp":1555962816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-018-0117-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1007\/s10822-018-0117-y","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"27 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}